COVID-19 News & Resources

 Updated: August 7, 2020

  Tags: COVID-19

COVID-19 photo
AARC initiated remote operations on Monday, March 23. AARC staff will work remotely from 8 a.m to 5 p.m.
image of microphone with aarc experts in the news
AARC leaders and members have been fielding media questions from all over the U.S. Check out their stories.

The American Association for Respiratory Care (AARC) wants all respiratory therapists to be fully prepared and equipped with the up-to-date information regarding COVID-19. As we know this is an ever-changing situation and one that can easily be miscommunicated to others. Below are links to Centers for Disease Control (CDC), which is providing the best comprehensive information. It is updated on a daily basis.

How many people have been affected by COVID-19?
How many people have been diagnosed/hospitalized/died in the United States?
What are the symptoms of COVID-19?
How do people get tested for COVID-19?
What do I do if I’ve been exposed to COVID-19 at work?
How do I protect myself in the community?
How do I protect myself in the workplace? What PPE are required?
What infection control measures should we use in the workplace?
How do we care for COVID-19 positive persons in the home?
Healthcare FAQ from the CDC for further reading.

National Stockpile Ventilators

In addition, we encourage respiratory therapists to view the video presentations about the Strategic National Stockpile Ventilators. In the event that there is a shortage of ventilators, these ventilators can be put into service, and it is critical that respiratory therapists know how to operate the stockpile ventilators, should the need arise. There have been several live presentations about the stockpile ventilators throughout the country hosted by the AARC in the last several years and we expect to do more in 2020.

Joint Statement on Multiple Patients on One Ventilator

The AARC issued a joint statement with various professional medical organizations from across the U.S. this week, addressing the question of placing multiple patients on one ventilator. The statement advises clinicians that sharing mechanical ventilators should not be attempted because it cannot be done safely with current equipment.

Read the Full Statement

The AARC also prepared a Guidance Document to accompany the statement. Since then, the document has been updated. The authors and AARC continue to monitor the science and best practice around COVID-19, updating the Guidance Document where appropriate based on new, reliable information from those dedicated teams in those pandemic hot spots.

Review the Guidance Document

Multiplex Ventilation: A Simulation-based Study of Ventilating Two Patients with One Ventilator

Background: The overwhelming demand for mechanical ventilators due to COVID-19 has stimulated interest in using one ventilator for multiple patients (multiplex ventilation). Despite a plethora of information on the Internet, there is little supporting evidence and no human studies. The risk of multiplex ventilation is that ventilation and PEEP effects are largely uncontrollable and depend on the difference between patient resistance, (R) and compliance (C). It is not clear whether volume control or pressure control is safer or more effective. We designed a simulation-based study to allow complete control over the relevant variables to determine the effects of various degrees of RC imbalance on tidal volume (VT), end-expiratory lung volume (VEE), and imputed pH.

Results: Depending on differences in R and C, differences in VT ranged from 1% (equal R and C) to 79%. Differences in VEE ranged from 2% to 109%. Differences in pH ranged from 0% to 5%. Failure due to excessive tidal volume (> 8 mL/kg) did not occur. Failure due to excessive VEE difference (> 10%) was evident in 50% of patient pairs. There was no difference in failure rate between VC and PC.

Conclusions: These experiments confirmed the potential for markedly different ventilation and oxygenation for patients with uneven respiratory system impedances during multiplex ventilation. Three critical problems must be solved to minimize risk: (1) partitioning of inspiratory flow from the ventilator individually between the two patients, (2) measurement of VT delivered to each patient, and (3) provision for individual PEEP. We provide suggestions for solving these problems.

Fast Track Study Published in RESPIRATORY CARE.

Review the Study

Webinar: Effective Patient Care During a Pandemic

The AARC partnered with the Society of Critical Care Medicine (SCCM) to host a webcast “Maximizing the Respiratory Team Dynamic: Effective Patient Care During a Pandemic,” which took place on May 14.

Watch the Recorded Webinar

This program is sponsored in part by an unrestricted educational grant from Draeger & Mylan.

CMS Issues Interim Final Rule on Clinical Indications for Certain Respiratory, Home Anticoagulation Management and Infusion Pump Policies

CMS issued an interim final rule that provides an array of temporary regulatory waivers and new rules to equip the American health care system with maximum flexibility to respond to the 2019 Novel Coronavirus (COVID-19) pandemic. The one that applies to respiratory is highlighted below:

During the PHE for the COVID-19 pandemic, it is possible that patients receiving services for respiratory related indications will be required to receive care in unexpected settings, including the home. This may be necessary as COVID-19 and other patients are shifted across healthcare settings to accommodate an increase in patient volume. Therefore, we are finalizing on an interim basis that we will not enforce the clinical indications for coverage across respiratory, home anticoagulation management and infusion pump NCDs and LCDs (including articles) allowing for maximum flexibility for practitioners to care for their patients. This enforcement discretion will only apply during the PHE for the COVID-19 pandemic. These policies include, but are not limited to:

    • NCD 240.2 Home Oxygen.
    • NCD 240.4 Continuous Positive Airway Pressure for Obstructive Sleep Apnea.
    • LCD L33800 Respiratory Assist Devices (ventilators for home use).
    • NCD 240.5 Intrapulmonary Percussive Ventilator.
    • LCD L33797 Oxygen and Oxygen Equipment (for home use).
    • NCD 190.11 Home Prothrombin Time/International Normalized Ratio (PT/INR)

Definitions:
NCD – National Coverage Determination
LCD – Local Coverage Determination
PHE – Public Health Emergency

Leading Health Care Groups Issue Urgent Call for Federal Action to Address Medical Equipment Shortages

As longstanding organizations representing and supporting those on the front lines who are risking their lives caring for the world’s most vulnerable patients, we stand united in voicing our concern over the critical shortages of medical equipment, including ventilators, test kits and all types of personal protective equipment (PPE) such as masks, face shields and gowns, to adequately address the COVID-19 public health crisis. Read the full statement.


Need supplies?

The Patient Safety Movement Foundation is partnering with the COVID-19 Help Network to help connect businesses and hospitals in need to provide essential personal protective equipment (PPE) and supplies to respond to the pandemic. If your hospital is in need of PPE or other essential supplies complete this online form.


New Video! Bilevel Devices Converted to Ventilators

Watch AARC’s video to learn about using a ventilator designed for NIV to provide invasive ventilation.


FDA’s Recommendations for Ventilator Supply Mitigation Strategies

Recognizing that the need for ventilators and ventilator-related accessories may outpace the available supply, the FDA issued recommendations based on their recent “Enforcement Policy” guidance. The FDA reminds health care professionals that your patient’s condition, the available technology, and the respiratory care expertise and experience present in your institution should be considered when choosing the appropriate ventilation for your patient. According to the FDA, their “recommendations are intended to augment, not replace, specific controls and procedures developed by health care organizations” and the CDC.

Read the Recommendations

BOMA Letter Urges U.S. Surgeon General to Recognize RTs

Peter Papadakos, MD, FCCM, FCCP, FAARC, chair of the AARC Board of Medical Advisors (BOMA), sent a letter to the U.S. Surgeon General, asking for assistance in recognizing respiratory therapists. The letter brings to light the need to recognize the valuable contributions respiratory therapists make each day as they work to fight the COVID-19 virus.

“Respiratory therapists have played a key role in my career in critical care,” Dr. Papadakos said. “A number of my therapists have joined me in research projects that have lead to multiple publications in Mechanical Ventilation, ARDS and NIV. I owe you all a debt of gratitude for all you do from the neonatal ICU to the point of end of life.”

Download the Letter

Surviving Sepsis Campaign COVID-19 Guidelines

SCCM has released its Surviving Sepsis Campaign COVID-19 guidelines to manage critically ill adults with COVID-19 in the intensive care unit (ICU). This guideline is expected to be updated as new evidence becomes available.

AARC Letters to Leaders

The AARC sent letters to U.S. Vice President Mike Pence, U.S. Congress, the Department of Health and Human Services, and the Centers for Medicare and Medicaid Services. These letters advocate for the role of the respiratory therapist during this crisis and beyond.

Letter to U.S. VP Pence
Letter to U.S. Congress
Letter to CMS & HHS

On Apr. 14, 2020, the AARC sent a letter to the U.S. Congress, urging them to recognize respiratory therapists essential health care workers. RTs deliver lifesaving care to patients with COVID-19. This letter recommends specifically recognizing RTs as essential health care providers in any legislative provision authorizing hazard pay for essential workers, like the Heroes Fund proposal, and allowing them to deliver care to Medicare beneficiaries via telehealth.

AARC Letter on Heroes Fund

On May 5, 2020, President Schell and Dr. Peter Papadakos, Chair of AARC’s Board of Medical Advisors, reached out to Jared Kushner, Senior Advisor to the President, recommending the Administration use the expertise of the AARC in an advisory role moving forward in any decisions that impact access to ventilators.

AARC Letter to Jared Kushner


State Licensure and Telehealth Waivers During the Pandemic

As states continue to implement emergency declarations, the Federation of State Medical Boards keeps track of details on what states are doing to lift licensing laws to permit health care professionals to work across state lines and to provide telehealth services. You may also want to check with the licensing board in your state that governs respiratory therapists.

Interview with Dr. Michael Anderson

As an authority on children’s health policy, pediatric disaster preparedness, system quality and physician workforce, Michael R. Anderson, MD, MBA, FAAP, FAARC, took a moment to speak with the AARC. He is a supporter of respiratory therapists, and a proud fellow of the AARC. In this conversation, Dr. Michael Anderson discusses COVID-19 and important aspects relevant to the respiratory therapist’s ability to provide safe and effective care.

Enable cookies to see embeded content.


Discussion From Washington State

On Mar 18, 2020, AARC Adult Acute Care Section Chair Carl Hinkson MSRC, RRT, RRT-ACCS, RRT-NPS FAARC dedicated time to a discussion of COVID-19. Hinkson and colleague Darryl Keffer RRT shared their experiences caring for patients diagnosed with COVID-19.

Enable cookies to see embeded content.


Join the COVID-19 Conversation

The AARC opened an AARConnect community dedicated to sharing COVID-19 resources and dialoguing about challenges and solutions during this outbreak. The AARConnect community is free and open to all members. Just go to the community page and join the discussion.

Trending Questions from the Community:

Should I use noninvasive ventilation or high-flow nasal cannula for my patient with COVID-19?
Some studies have indicated that HFNC and NIV have not been useful in treating patients with COVID-19. Studies have shown that there is a potential for secondary inhalation of emissions released from the patient on HFNC. Some recommend placing these patients in negative-pressure rooms if HFNC is used. There are some recommendations from clinicians about proper ways to manage these patients in the ICU.

Should I aerosolize medications for my patient?
CDC’s guidance on aerosol generating procedures (AGPs):

    • Some procedures performed on a patient with known or suspected COVID-19 could generate infectious aerosols. In particular, procedures that are likely to induce coughing (e.g., sputum induction, open suctioning of airways) should be performed cautiously and avoided if possible.
    • If performed, the following should occur:
      • HCP in the room should wear an N95 or higher-level respirator, eye protection, gloves, and a gown.
      • The number of HCP present during the procedure should be limited to only those essential for patient care and procedure support. Visitors should not be present for the procedure.
      • AGPs should ideally take place in an AIIR (airborne infection isolation room).
      • Clean and disinfect procedure room surfaces promptly as described in the section on environmental infection control below.

If you want to stay up-to-date on the latest publications, search PubMed with this automated search.

For RT tips for safety and links to members in the news on this topic go to our RTs, Thank You for Fighting COVID-19 page.